Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors

Aoife M. Egan, Victor M. Montori

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)JC2
JournalAnnals of internal medicine
Volume169
Issue number2
DOIs
StatePublished - Jul 17 2018

ASJC Scopus subject areas

  • Internal Medicine

Cite this